Company Overview and News
Marmota Ltd (ASX:MEU) has released the first recordings of visible gold at its Aurora Tank project in South Australia.
Marmota Ltd (ASX:MEU) has received high grade gold results from drilling at the Aurora Tank project in South Australia.
WPG Resources Ltd (ASX:WPG) has executed a memorandum of understanding (MoU) with Marmota Ltd (ASX:MEU) regarding the Aurora Tank Gold Project in South Australia.
Marmota (ASX:MEU) has received high-grade gold intersections from the June/July drilling program at the Goshawk Prospect, part of the Aurora Tank Gold Project in South Australia.
Marmota (ASX:MEU) has been granted a trading halt by the ASX, pending details related to a capital raising via placement.
Marmota’s (ASX:MEU) phase 2 drilling program at its Aurora Tank Gold Project in South Australia has returned multiple significant gold intersections, all close to the surface.
Marmota Energy’s (ASX:MEU) phase 2 drilling program at its Aurora Tank Gold Project in South Australia has returned multiple significant gold intersections, all close to the surface.
Marmota requested the halt pending drilling results from the Aurora Tank tenement, which is located in South Australia.
The company’s shares were last trading at $0.019, up 11.76% intraday. Kingsgate Consolidated Ltd’s (ASX:KCN) Challenger mine has produced over one million ounces of gold (i.e. over $1.68 billion at current prices). Marmota is searching for Challenger-style gold systems in its tenements covering about 5,300 square kilometres of prospective area in the Gawler Craton. The new tenements add a further 480 square kilometre of highly prospective ground, consolidating Marmota’s portfolio in the area.
The halt will remain in place until the opening of trade on Tuesday 25th October 2016, or earlier if an announcement is made to the market.
Marmota Energy Ltd (ASX:MEU) has successfully completed its share purchase plan, with eligible shareholders applying for $530,000 of shares, which is more than 75% over the $300,000 target. The shares will be issued at $0.015 each. Last week, Marmota completed a 4,385 metre drilling program at the Aurora Tank Gold Project, 50 kilometres northeast of the Challenger Gold Mine in South Australia. The drilling program was to test the Goshawk Prospect at Aurora Tank with the intention of fully defining geochemical dispersion from gold mineralisation.
Marmota Energy Ltd (ASX:MEU) has started a 4900 metres drilling program at the Aurora Tank Gold Project, 50 kilometres northeast of the Challenger Gold Mine in South Australia. Kingsgate Consolidated Ltd’s (ASX:KCN) Challenger mine has produced over one million ounces of gold (i.e. over $1.7 billion at current prices). Marmota is searching for Challenger-style gold systems in its tenements covering about 5,300 square kilometres of highly prospective area in the Gawler Craton.
Marmota Energy Ltd (ASX:MEU) is an integrated precious metal and uranium exploration company with a pipeline of discovery opportunities.
16h - Asif
Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...
16h - Asif
Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...